Transaction #14142 · Form 4 · 0001771961-25-000009
Arcus Biosciences, Inc. · Exercise / conversion · Common Stock
Arcus Biosciences, Inc. · Transacted November 26, 2025 · Filed December 1, 2025
What does this filing report?
An SEC Form 4 filing for Arcus Biosciences, Inc. records an exercise / conversion involving Common Stock on November 26, 2025. The reported quantity was 1,900. The filing date is December 1, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Arcus Biosciences, Inc.
- Company CIK
- 0001724521
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 1,900
- Reported price
- 13.33
- Reference value
- 25,327
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 29,263
- Ownership description
- Not reported
- SEC acceptance time
- Dec 1, 2025, 6:09 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Azoy Alexander ↗
Chief Accounting Officer
CIK 0001771961
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2
- The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.